Johnson and Johnson and Bayer AG are currently in the process of settling approximately one dozen lawsuits associated with the blood thinning medication Xarelto. These lawsuits were filed against the manufacturer of the drugs and alleged that companies failed to properly inform patients and doctors about the risks of using this medication.
The drugs came with no details about their being an antidote nor the fact that adjustments of dosage are frequently necessary. In addition to the variety of lawsuits already in progress, more are expected in coming months. Many of the companies have been reluctant to release many details about these lawsuits, but it’s clear that more patients are coming forward with concerns.
Have you already been injured? Have you experienced unexplained medical issues after taking Xarelto? If this blood thinning medication has left you with injuries and pain, you could be entitled to file a Xarelto lawsuit.
What Is Xarelto?
Xarelto is a popular blood thinning medication that is one of the newest options on the market. It was created to replace previous blood thinning and anticoagulant medications. The manufacturer received FDA approval in 2011 to use Xarelto for treating blood clot formation in patients suffering from pulmonary embolism and deep vein thrombosis. The medication was also intended to prevent blood clotting in patients with non-valve atrial fibrillation, DVT or PE, and hip or knee replacements.
Within two years of coming to the market, backlash against Xarelto began including more than 700 reports of adverse actions.
Some of the most common side effects of using Xarelto include:
- Low blood pressure
- Muscle pain
Symptoms associated with internal bleeding might also present in the patient and can include:
- Pale skin
- Unexplained bruising
- Extreme fatigue
- abdominal swelling
- Eye or nose bleeding
- Loss of consciousness
- Stroke symptoms
- Sudden and extreme unexplained pain
- Urinary, rectal or genital bleeding
Any of the mild indications of a side effect problem with Xarelto could be signs of a more serious problem. While you may be able to use Xarelto safely, dosage adjustments are frequently necessary. Doctors, however, were not made aware of the high likelihood for dosage adjustments.
The lawsuits currently in progress allege that Bayer and Johnson & Johnson made no effort to warn users about these potential dosage adjustments. The Xarelto website providing information for healthcare professionals allegedly did not include correct information about dosage for medication users.
While the mistake was corrected in 2014, doctors were not notified of the error until June of that same year. It is not clear whether or not the incorrect information on that site led to any adverse events. If patients and doctors had been warned about the risks, similar medications without these dangerous side effects could have been used instead.
Risks of Using Xarelto
Xarelto is different from previous medications intended for similar purposes because laboratory testing is not done to generate personalized treatment plans. This means that there’s no antidote to Xarelto – a fact that manufacturers did not share with doctors. If a blood thinner causes bleeding, for example, there is no way to counteract it and some of the family members involved in lawsuits today allege that these bleeding episodes were fatal.
With the risk of uncontrollable bleeding for all users, there’s also a higher risk for elderly patients using Xarelto. Cranial bleeding could lead to a disability or fatality. This risk is even higher after a fall. Although there are black box warnings about the risk of spinal bleeding following spinal trauma or procedures, Xarelto could present other problems for individuals taking the medication. Consult more with the attorneys at Seeger Weiss to learn more about your rights.
Free Case Evaluation
The U.S. Environmental Protection Agency (EPA) accused Fiat Chrysler of installing software on over 100,000 trucks and SUVs that underreported the amount of pollutants the vehicles spewed into the [...]January 12, 2017 By: Seeger Weiss read more